Interclean Shanghai

Hocoma launches a new version of its established gait training device LokomatPro

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

EU Begins Revision of Medical Device...

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical...

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI...

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...
Since the launch of Hocoma’s first gait therapy device in 2001, the LokomatPro has established itself as an effective intervention for improving over-ground walking function in patients who suffer of neurological diseases and injuries resulting in gait impairment. In strong collaboration with clinical research partners, Hocoma has now developed a new and more compact version of the LokomatPro. The new version of the LokomatPro has been developed with the needs of patients and clinics in mind and provides extensive locomotion therapy to help patients trigger great improvements.

It features a new and more compact design and is equipped with the Augmented Feedback and a touch screen as a standard. In the future, upgrading options (e.g. additional degrees of freedom at the hip joint, sophisticated control strategy, higher gait speed) will extend the LokomatPro as a sophisticated gait training device supporting the therapists and the patients in reaching their therapy goals. As the preceding versions, with the optional Pediatric Orthoses, the LokomatPro provides intensive locomotion therapy also for the treatment of children with cerebral palsy or other neurological disorders.

Latest stories

Related stories

EU Begins Revision of Medical Device Regulatory Framework

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical Devices Regulation

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI Rollout in the NHS

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »